Zobrazeno 1 - 10
of 281
pro vyhledávání: '"Levinus A Dieleman"'
Autor:
Subrata Ghosh, Levinus A Dieleman, Christopher Ma, Ian Lewis, Herman W Barkema, Humberto Jijon, Kathy D McCoy, Georgios V Gkoutos, Maitreyi Raman, Lorian M Taylor, Jeff K Vallance, Derek M McKay, David M Mutch, Deanna Gibson, Marcus Rauch
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Introduction Dietary patterns that might induce remission in patients with active Crohn’s disease (CD) are of interest to patients, but studies are limited in the published literature. We aim to explore the efficacy of the CD therapeutic dietary in
Externí odkaz:
https://doaj.org/article/519cdb9c6d2948169c34acac6b097c7d
Autor:
Farhad Peerani, Makayla Watt, Kathleen P Ismond, Reid Whitlock, Lindsy Ambrosio, Naomi Hotte, Nicholas Mitchell, Robert J Bailey, Karen Kroeker, Levinus A Dieleman, Jesse Siffledeen, Allen Lim, Karen Wong, Brendan P Halloran, Daniel C Baumgart, Lorian Taylor, Maitreyi Raman, Karen L Madsen, Puneeta Tandon
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Psychological stress negatively impacts inflammatory bowel disease (IBD) outcomes. Patients have prioritized access to online interventions; yet, the data on these have been limited by mixed in-person/online interventions, low adherence,
Externí odkaz:
https://doaj.org/article/d3602a1a8b3d476eafe3aa308d64cac1
Autor:
Russell J de Souza, Sandra Zelinsky, Levinus A Dieleman, Laura Targownik, Paul Moayyedi, Jennifer Cunningham, Glenda MacQueen, Stephen Vanner, Premysl Bercik, Karen L Madsen, John D Rioux, Elena Verdú, Anthony Otley, Aida Fernandes
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction Gut microbiome and diet may be important in irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and comorbid psychiatric conditions, but the mechanisms are unclear. We will create a large cohort of patients with IBS, IBD and
Externí odkaz:
https://doaj.org/article/4cc3e581f8a548d89262476fda14c94f
Autor:
Christopher Ma, Chad J Evaschesen, Grenvil Gracias, Vivian W Huang, Darryl K Fedorak, Karen I Kroeker, Levinus A Dieleman, Brendan P Halloran, Richard N Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 309-314 (2015)
BACKGROUND: Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled
Externí odkaz:
https://doaj.org/article/8dfd2d200003405ead0b6d20c4c75971
Autor:
Vivian W Huang, Hsiu-Ju Chang, Karen I Kroeker, Karen J Goodman, Kathleen M Hegadoren, Levinus A Dieleman, Richard N Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 2, Pp 95-103 (2015)
BACKGROUND: Women with inflammatory bowel disease (IBD) may choose to remain childless due to a lack of IBD-specific reproductive knowledge.
Externí odkaz:
https://doaj.org/article/8b46c6706f73471c8b1be7da1c17bd45
Autor:
María E Negrón, Herman W Barkema, Kevin Rioux, Jeroen De Buck, Sylvia Checkley, Marie-Claude Proulx, Alexandra Frolkis, Paul L Beck, Levinus A Dieleman, Remo Panaccione, Subrata Ghosh, Gilaad G Kaplan
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 7, Pp 373-380 (2014)
BACKGROUND: The impact of Clostridium difficile infections among ulcerative colitis (UC) patients is well characterized. However, there is little knowledge regarding the association between C difficile infections and postoperative complications among
Externí odkaz:
https://doaj.org/article/11fbc3e398de4a86b095e0173ee71abe
Autor:
Christopher W Teshima, Adrienne Thompson, LeRose Dhanoa, Levinus A Dieleman, Richard N Fedorak
Publikováno v:
Canadian Journal of Gastroenterology, Vol 23, Iss 5, Pp 348-352 (2009)
BACKGROUND: Infliximab’s efficacy in the induction and maintenance of remission in luminal Crohn’s disease has been confirmed by randomized, controlled trials. Less clearly described are long-term outcomes in the clinical practice setting since t
Externí odkaz:
https://doaj.org/article/febb7a703ed042ae976f7e153575ff6d
Autor:
Remo Panaccione, Richard N Fedorak, Guy Aumais, Edmond-Jean Bernard, Charles N Bernstein, Alain Bitton, Ken Croitoru, Levinus A Dieleman, Robert Enns, Brian G Feagan, Denis Franchimont, Gordon R Greenberg, Anne-Marie Griffiths, John K Marshall, Pierre Pare, Sunil Patel, Robert Penner, Craig Render, Ernest Seidman, A Hillary Steinhart
Publikováno v:
Canadian Journal of Gastroenterology, Vol 22, Iss 3, Pp 261-272 (2008)
Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments
Externí odkaz:
https://doaj.org/article/8599be4e6b0d4a07a1282e835b9551d1
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111717 (2014)
Non-digestible oligosaccharides (NDO) were shown to reduce inflammation in experimental colitis, but it remains unclear whether microbiota changes mediate their colitis-modulating effects. This study assessed intestinal microbiota and intestinal infl
Externí odkaz:
https://doaj.org/article/1f913477676b4ad9aa4730b33077aa6f
Autor:
Alexandra Frolkis, Levinus A Dieleman, Herman W Barkema, Remo Panaccione, Subrata Ghosh, Richard N Fedorak, Karen Madsen, Gilaad G Kaplan, on behalf of the Alberta IBD Consortium
Publikováno v:
Canadian Journal of Gastroenterology, Vol 27, Iss 3, Pp e18-e24 (2013)
Inflammatory bowel diseases (IBD), which consists of Crohn disease and ulcerative colitis, are chronic inflammatory conditions of the gas-trointestinal tract. In genetically susceptible individuals, the interaction between environmental factors and n
Externí odkaz:
https://doaj.org/article/93b1a57bee484a80961bd960938731e3